HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Haskell Selected Research

Hemorrhage

1/2018Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.
4/2014D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Haskell Research Topics

Disease

2Hemorrhage
01/2018 - 04/2014
1Communicable Diseases (Infectious Diseases)
01/2018
1Infections
01/2018
1Venous Thromboembolism
04/2014
1Neoplasms (Cancer)
04/2014

Drug/Important Bio-Agent (IBA)

2Enoxaparin (Lovenox)FDA LinkGeneric
01/2018 - 04/2014
1RivaroxabanIBA
01/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1fibrin fragment D (D-dimer)IBA
04/2014